Thames Freeport, in collaboration with Rainmaking and Care City, has launched their health and care accelerator with a cohort of six innovative Korean startups, each tackling critical health and care challenges facing the UK’s ageing population.
Datapharm, a provider of medicines information in the UK, has announced its continued expansion into Europe through a new strategic partnership with VIDAL.
ProductLife Group (PLG) has announced the acquisition of HERAX Life Science, a Danish business and technology consultancy providing tailored services and solutions for the life sciences industry.
Oxford Drug Design has been awarded £1m in funding to progress its uUTI (uncomplicated urinary tract infection) antibacterial programme, as announced by PACE (Pathways to Antimicrobial Clinical Efficacy).
Nuclera, the biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery system, has announced the appointment of William J. Kullback to its board of directors as a non-executive director (NED).
Infex Therapeutics, an anti-infectives specialist, has announced that in collaboration with Justus-Liebig-University Giessen, it has been awarded a £1 million grant from PACE, to develop a BamA inhibitor.
Betacom has announced a partnership with Siemens Industries. The companies have deployed a private 5G network platform at MxD (Manufacturing x Digital), the National Center for Cybersecurity in Manufacturing in Chicago.
